AIRPORT
5014
GAMUDA
5398
SIMEPROP
5288
SUNWAY
5211
IJM
3336
MY Stock MarketDetailed Quotes
6599 AEON
- 1.490
- -0.030-1.97%
15min DelayTrading Jan 23 11:48 CST
2.09BMarket Cap15.36P/E (TTM)
1.520High1.490Low412.50KVolume1.520Open1.520Pre Close617.24KTurnover1.61052wk High0.06%Turnover Ratio1.40BShares1.04052wk Low0.097EPS TTM960.18MFloat Cap4.944Historical High18.17P/E (Static)644.42MShs Float0.021Historical Low0.082EPS LYR1.97%Amplitude0.04Dividend TTM1.09P/B100Lot Size2.68%Div YieldTTM
AEON News
Aeon Thana Sinsap (Thailand) Target Price Raised to THB160.00 From THB158.00 by UOB Kay Hian >AEONTS.TH
J.P. Morgan Reaffirms Their Sell Rating on AEON Co (AONNF)
Aeon Mall Upgraded to Buy From Neutral at Goldman Sachs
Aeon Thana Sinsap (Thailand) Raised to Buy From Hold by UOB Kay Hian >AEONTS.TH
Aeon Thana Sinsap (Thailand) Target Price Raised to THB158.00 From THB150.00 by UOB Kay Hian >AEONTS.TH
Aeon Co.(M) Target Price Raised to MYR1.95 From MYR1.86 by Maybank IB >6599.KU
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $5 Price Target
Buy Rating on AEON Biopharma: Strategic FDA Alignment and Positive Long-Term Revenue Projections
AEON Thana Sinsap (Thailand) Target Price Raised to THB150.00 From THB148.00 by UOB Kay Hian >AEONTS.TH
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Maintains Buy on AEON Biopharma, Lowers Price Target to $5
AEON Biopharma Analyst Ratings
Buy Rating Affirmed for AEON Biopharma on Strategic Biosimilar Pathway and Promising Phase 3 Study Prospects
AEON Biopharma Analyst Ratings
Buy Rating Affirmed for AEON Biopharma: Strategic Cost-Cutting and ABP-450's Broad Market Potential
AEON Biopharma Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: AEON Biopharma (AEON), Palatin Technologies (PTN)
AEON Biopharma Analyst Ratings
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $18 Price Target